Hainan Province issued a document | diagnostic reagents national lowest price procurement

Medical Network June 11th Following Sichuan, Shanxi and Anhui provinces, Hainan became the fourth province in the country to purchase the entire IVD province, and required the lowest price in the country.

On June 7, the Hainan Provincial Health Planning Commission issued the "Implementation Plan for Centralized Sunlight Purchasing of In-vitro Diagnostic Test Reagents for Hainan Provincial Public Medical and Health Institutions." After half a year of seeking opinions, the province's centralized procurement was officially launched.

In this program, it is clearly stated that the goal of collective procurement is to 'promote the rationalization of purchase prices gradually and reduce the inflated prices of in vitro diagnostic test reagents.'

It can be predicted that drug , After high-value consumables, in-vitro diagnostic test reagents will usher in the tender, the era of collection and price reduction.

The procurement method is online centralized procurement. The public medical and health institutions purchase according to clinical needs, and exchange prices by quantity, price, and price to further reduce the purchase price of in vitro diagnostic test reagents.

The price of the products in the province's winning bids, and the price of the hanging nets: According to the implementation plan of this province, since 2015, provincial-level bidding prices of all provinces, municipalities, and autonomous regions across the country are being implemented, and the lowest price of the hanging net limit; Hainan Province 2 The minimum actual purchase price of a public health institution above the level (inclusive). Take the low value of both as the limit price.

There is no provincial price, the price limit for hanging the net, but there are products in the public medical and health institutions in Hainan Province, the manufacturer provides the Hainan Provincial public health agencies the actual purchase of the lowest price, and upload sales invoices issued to the medical institutions, According to the second-level (inclusive) or above, the minimum actual purchase price of public health institutions in Hainan Province is the limit price.

There is no product related to the province's winning bid price, the price limit for hanging the net, nor the product of the purchase price of the public medical and health institutions in Hainan Province.

If the company quotations are not true, during the public notice, all parties will accept complaints and complaints. If it is impossible to clarify the facts, if the circumstances are serious, cancel the qualification of their products.

Online centralized purchasing of products in the catalogue is subject to voluntariness, fairness and impartiality by both public health institutions and enterprises, and the price is linked to the actual purchase price by the amount of price exchange.

In the case of non-compliance of penalties imposed on production companies, Hainan mainly proposes the following points, and imposes corresponding penalties, including kicking out of the procurement catalog, cancellation of online qualifications, etc., including:

In vitro diagnostic test reagent manufacturers have commercial bribery;

Provide false certification documents, or participate in the centralized connection network sunshine procurement in other fraudulent ways;

Conspiracy to manipulate transaction prices, arbitrarily increasing prices or disguised price increases for linked products;

The product found in the national quality sampling inspection is unqualified and publicized in the quality announcement;

Complaints due to quality problems and verified by food and drug regulatory authorities;

medical instruments (or pharmaceuticals) Registration certificates, production or business licenses, business licenses and other qualification certificates are revoked (revoked) by the relevant competent authorities.

It is reported that this time, Hainan's procurement period is uncertain. As with high-value consumables, Hainan reagent collection and procurement is also promoted in batches. The in-vitro diagnostic test reagents are divided into eight categories for clinical use, including clinical biochemical tests, and clinical immunizations. Tests, clinical blood analysis tests, clinical fluid tests, clinical molecular tests, clinical microbiological tests, clinical pathology and cytology tests, clinical POCT tests.

Purchasing catalogs divide in vitro diagnostic test reagents into general (open) in vitro diagnostic test reagents and special machine (closed) in vitro diagnostic test reagents according to the category of purchase.

General-purpose (open) in-vitro diagnostic test reagents procurement, direct cataloging according to catalogue classification.

Special-purpose (closed) in-vitro diagnostic test reagents are purchased, cataloged and cataloged for direct online procurement, and relevant information for the applicable instrument for the hooked product is displayed in the procurement catalog. The relevant information for the instrument is produced by in vitro diagnostic test reagents. enterprise Complete the report when reporting.

Before Hainan, Sichuan, Shanxi, and Anhui provinces had started the centralized procurement of diagnostic reagents, among which Sichuan was the earliest, but the price limit was gentle. Shanxi and Anhui, the price limit was much stricter.

In October 2016, Sichuan Province pioneered diagnostic reagents for the province's coal mining. For the setting of the reference price of the grid connection, the national minimum is not required, or it is lower than the neighboring provinces. It only requires the medical treatment collected by the Sichuan pharmaceutical exploration platform. The actual purchase price of the health institution forms the weighted average price as the reference price of the linked product.

From January 1, 2017, Shanxi Province promoted public hospital In-vitro diagnostic reagents are subject to price-based purchases, in which non-exclusive products are purchased at the lowest price; for exclusive products, they are directly reduced by 10%; if there are no transaction records in the province, the lowest price in other provinces is the transaction price.

In December 2017, Anhui Province issued the 'Practical Online Concentration Transaction Plan for Clinical Testing Reagents in Public Medical Institutions'. The testing reagents commonly used by public medical institutions in the province's public medical institutions were all included in the scope of centralized procurement. There were 413 production companies in total. proxy There are 67 enterprises, 490 distribution companies participate in the database application, and a total of nearly 40,000 products are declared.

The price limit is based on the provincial-level bidding price, the limit price of the grid connection, and the actual purchase price of the provincial and municipal public hospitals since 2014. The specific price limit method is: There are provincial prices, the price of products linked to the net is taken from the province's bidding price, the lowest price of the net price limit and the low value of the second lowest price of the provincial and municipal hospital's latest actual purchase price as the price limit; price, hanging net price of the product in accordance with provincial and municipal hospitals and the actual purchase price of the most recent median price down by 10% as a limit.